Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Necrosis: The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
Trial | Phase | Enrollment | Study Type | Start Date | Status |
Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction: a Double-Blind, Multicenter, Randomized, Placebo-Controlled Clinical Trial[NCT04912518] | | 250 participants (Anticipated) | Interventional | 2021-05-27 | Recruiting |
ASSessing the Effect of Anti-IL-6 Treatment in Myocardial Infarction: The ASSAIL-MI Trial[NCT03004703] | Phase 2 | 200 participants (Actual) | Interventional | 2017-03-16 | Completed |
"Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion. The MEEffect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion (METOCARD-CNIC): A Randomized, Controlled Parallel-group, Observer-blinded Clinical Trial[NCT01311700] | Phase 4 | 221 participants (Actual) | Interventional | 2010-11-30 | Completed |
Effect of Methotrexate Carried by a Lipid Nanoemulsion on Left Ventricular Remodeling After ST-elevation Myocardial Infarction[NCT03516903] | Phase 2/Phase 3 | 35 participants (Actual) | Interventional | 2018-04-17 | Terminated (stopped due to Due to the COVID-19 pandemic. With a second wave just beginning, and considering that we are testing an immunosuppressant in patients with high risk for COVID-19 complications, we would not be able to re-start recruitment safely in the near future.) |
Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome[NCT05536271] | Phase 2 | 127 participants (Actual) | Interventional | 2021-09-01 | Completed |
Potential Drug Interactions With Bisoprolol in Egyptian Patients With Acute Coronary Syndrome[NCT05536284] | Phase 2 | 128 participants (Actual) | Interventional | 2021-09-01 | Completed |
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Article | Year |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) triCirculation, 2013, Oct-01, Volume: 128, Issue:14
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiotonic Agents; Combined Modality Therapy; Creatine Kin | 2013 |
Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARAmerican heart journal, 2014, Volume: 168, Issue:5
Topics: Administration, Intravenous; Adrenergic beta-Antagonists; Combined Modality Therapy; Double-Blind Me | 2014 |
Article | Year |
Effect of ethanolic extract of Cyperus rotundus L. against isoprenaline induced cardiotoxicity.Indian journal of experimental biology, 2016, Volume: 54, Issue:10
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarker | 2016 |
Functional and histological assessment of an experimental model of Takotsubo's cardiomyopathy.Journal of the American Heart Association, 2014, Jun-23, Volume: 3, Issue:3
Topics: Adrenergic beta-Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Echo | 2014 |
Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.Pharmaceutical research, 2012, Volume: 29, Issue:6
Topics: Adrenergic Antagonists; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti | 2012 |
Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance.Circulation, 2007, Jun-12, Volume: 115, Issue:23
Topics: Animals; Magnetic Resonance Imaging; Metoprolol; Myocardial Infarction; Myocardial Ischemia; Myocard | 2007 |
Low-dose combination therapy with metoprolol and captopril for congestive heart failure in mice.Cardiovascular drugs and therapy, 1993, Volume: 7, Issue:5
Topics: Animals; Captopril; Drug Therapy, Combination; Female; Heart Failure; Heart Ventricles; Metoprolol; | 1993 |
Comparison of different pharmacological interventions on enzymatic parameters during acute myocardial infarction.Clinical biochemistry, 1987, Volume: 20, Issue:6
Topics: Adult; Aged; Clinical Enzyme Tests; Creatine Kinase; Dipyridamole; Female; Heart; Heparin; Humans; I | 1987 |
Postcountershock myocardial damage after pretreatment with adrenergic and calcium channel antagonists in halothane-anesthetized dogs.Anesthesiology, 1985, Volume: 62, Issue:5
Topics: Anesthesia, Inhalation; Animals; Calcium Channel Blockers; Dogs; Electric Countershock; Female; Halo | 1985 |